Anti-Müllerian Hormone (AMH): Function and Fertility Testing

An AMH blood test is commonly used to estimate the number of small follicles remaining in the ovaries. It may help fertility specialists predict whether the ovaries are likely to produce a low, average, or high number of eggs during treatment.

However, AMH cannot tell exactly how many eggs remain, whether those eggs are healthy, or whether someone can become pregnant naturally.

• anti-, meaning acting against or preventing;
• Müllerian, referring to the Müllerian ducts;
• hormone, a chemical messenger produced by the body.

The abbreviation is written in capital letters:

• The clinician ordered an AMH blood test.
• Her anti-Müllerian hormone level was interpreted with other fertility tests.
• AMH may help predict ovarian response during IVF.

Common expressions include:

• AMH level;
• low AMH;
• high AMH;
• ovarian-reserve testing;
• AMH blood test;
• age-related decline in AMH.

When functioning testes are present, Sertoli cells produce AMH. The hormone causes the Müllerian ducts to regress.

This process helps prevent development of:

• the uterus;
• the fallopian tubes;
• the cervix;
• the upper portion of the vagina.

Testosterone and other hormones guide development of different reproductive structures. AMH is therefore one part of a larger developmental system rather than the only hormone involved.

These follicles contain immature eggs. AMH production is generally highest in the earlier stages of follicle development and becomes lower as follicles mature.

Because the number of small follicles usually declines with age, AMH levels also tend to decrease over time.

AMH can often be measured on different days of the menstrual cycle because it usually varies less across the cycle than hormones such as FSH. However, results can still be affected by biological and laboratory variation.

AMH is one marker used to estimate this reserve. Other information may include:

• age;
• menstrual history;
• antral follicle count;
• FSH level;
• estradiol level;
• medical and surgical history.

A lower AMH level may suggest fewer remaining follicles. A higher level may suggest a greater number of small follicles.

Neither result should be interpreted alone.

• estimating ovarian reserve;
• planning fertility treatment;
• predicting ovarian response to stimulation;
• choosing medication doses during IVF;
• investigating certain ovulation disorders;
• assessing ovarian function after surgery or medical treatment;
• supporting evaluation of some reproductive-development conditions.

The test provides information about follicle quantity more than egg quality.

• whether a person is currently fertile or infertile;
• the exact number of eggs remaining;
• whether natural pregnancy will happen;
• the quality or genetic health of eggs;
• the exact age menopause will begin;
• whether a pregnancy will continue successfully;
• whether fertility treatment will produce a live birth.

Age remains an important factor because egg quality generally changes over time even when AMH is relatively high.

• age-related decline in ovarian reserve;
• reduced ovarian function;
• previous ovarian surgery;
• chemotherapy or radiation;
• some genetic conditions;
• primary ovarian insufficiency;
• individual biological variation.

Low AMH does not mean that pregnancy is impossible. Some people with low levels conceive naturally, while others with higher levels experience infertility for unrelated reasons.

A low result may be more useful for predicting a lower response to ovarian stimulation than for predicting natural conception.

It is commonly seen in some people with polycystic ovary syndrome, or PCOS. However, high AMH alone does not establish a PCOS diagnosis.

During fertility treatment, high AMH may predict a strong response to ovarian-stimulation medication. This can be useful for planning treatment but may also indicate a greater risk of excessive ovarian response.

Clinical interpretation should include symptoms, ultrasound findings, menstrual patterns, and other hormone tests.

The result may influence:

• medication dosage;
• treatment expectations;
• monitoring plans;
• discussion of egg retrieval numbers;
• risk assessment for ovarian hyperstimulation.

AMH is especially useful for predicting ovarian response, but it cannot guarantee embryo quality, implantation, pregnancy, or live birth.

Levels may become very low or undetectable near menopause. However, one AMH result cannot accurately predict the exact date of a person’s final menstrual period.

Menopause assessment usually depends on:

• age;
• menstrual history;
• symptoms;
• other clinical information.

AMH testing is not routinely required to diagnose natural menopause.

It may help clinicians assess:

• whether functioning testicular tissue is present;
• some differences in sex development;
• undescended or non-palpable testes;
• certain gonadal conditions;
• early or delayed reproductive development.

Results must be interpreted according to age, anatomy, other hormone levels, imaging, and genetic information.

Before interpreting the result, a clinician may consider:

• age;
• menstrual and reproductive history;
• hormonal contraception;
• pregnancy status;
• previous ovarian surgery;
• fertility treatment;
• chemotherapy or radiation;
• laboratory reference ranges.

Different laboratories may use different testing methods, so values from separate laboratories may not be directly comparable.

• age;
• ovarian surgery;
• chemotherapy;
• certain genetic conditions;
• PCOS;
• hormonal contraception;
• pregnancy;
• laboratory method;
• individual biological variation.

A temporary or modest change does not necessarily represent a major change in fertility.

• AMH reflects hormone production from small ovarian follicles.
• FSH reflects pituitary stimulation of the ovaries.
• Antral follicle count uses ultrasound to count visible small follicles.

These measures are often interpreted together because no single test provides a complete picture of reproductive potential.

Low AMH means pregnancy is impossible.
No. Pregnancy may still occur naturally or with treatment.

High AMH guarantees fertility.
No. Other factors, including egg quality, ovulation, sperm, and reproductive anatomy, also matter.

AMH measures egg quality.
No. It is used mainly as a marker of follicle quantity.

One AMH result predicts the exact age of menopause.
No. It cannot provide an exact personal timeline.

AMH is relevant only to adults seeking fertility treatment.
No. It also has an important role in fetal reproductive development and selected pediatric evaluations.

1. Anti-Müllerian hormone is produced by small ovarian follicles and fetal Sertoli cells.
2. The fertility specialist ordered an AMH blood test.
3. Can a low AMH level rule out natural pregnancy?
4. AMH may help predict ovarian response during IVF.
5. A high AMH level may occur in some people with PCOS.
6. The clinician interpreted AMH together with age and ultrasound findings.
7. AMH does not directly measure egg quality.
8. Understanding anti-Müllerian hormone helps readers discuss reproductive development, ovarian reserve, and fertility testing accurately.

AMH is primarily a reproductive and developmental hormone. It does not determine sexual orientation, gender identity, attraction, consent, or sexual desire.

Understanding AMH helps people interpret fertility testing more accurately and avoid treating one laboratory result as a complete judgment about reproductive ability or personal worth.